Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
Koulu M, Sjöholm B, Lappalainen J, Virtanen R. Koulu M, et al. Among authors: lappalainen j. Eur J Pharmacol. 1989 Oct 10;169(2-3):321-4. doi: 10.1016/0014-2999(89)90031-9. Eur J Pharmacol. 1989. PMID: 2530097
Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
Koulu M, Lappalainen J, Pesonen U, Hietala J, Syvälahti E. Koulu M, et al. Among authors: lappalainen j. Eur J Pharmacol. 1988 Oct 18;155(3):313-6. doi: 10.1016/0014-2999(88)90521-3. Eur J Pharmacol. 1988. PMID: 3069483
Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.
Lappalainen J, Hietala J, Syvälahti E. Lappalainen J, et al. Psychopharmacology (Berl). 1989;98(4):472-5. doi: 10.1007/BF00441944. Psychopharmacology (Berl). 1989. PMID: 2570432
Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?
Hietala J, Lappalainen J, Koulu M, Syvälahti E. Hietala J, et al. Among authors: lappalainen j. Trends Pharmacol Sci. 1990 Oct;11(10):406-10. doi: 10.1016/0165-6147(90)90147-z. Trends Pharmacol Sci. 1990. PMID: 2256181 Review.
Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
Lappalainen J, Hietala J, Koulu M, Seppälä T, Sjöholm B, Syvälahti E. Lappalainen J, et al. J Pharmacol Exp Ther. 1990 Feb;252(2):845-52. J Pharmacol Exp Ther. 1990. PMID: 2179533
5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.
Koulu M, Lappalainen J, Hietala J, Sjöholm B, Virtanen R. Koulu M, et al. Among authors: lappalainen j. Neuroreport. 1990 Oct;1(2):126-8. doi: 10.1097/00001756-199010000-00011. Neuroreport. 1990. PMID: 2151795
Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
Koulu M, Lappalainen J, Hietala J, Sjöholm B. Koulu M, et al. Among authors: lappalainen j. Psychopharmacology (Berl). 1990;101(2):168-71. doi: 10.1007/BF02244121. Psychopharmacology (Berl). 1990. PMID: 2140903
Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.
Hietala J, Salonen I, Lappalainen J, Syvälahti E. Hietala J, et al. Among authors: lappalainen j. Neurosci Lett. 1990 Jan 22;108(3):289-94. doi: 10.1016/0304-3940(90)90656-t. Neurosci Lett. 1990. PMID: 2137566
Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects.
Lappalainen J, Hietala J, Koulu M, Syvälahti E. Lappalainen J, et al. Eur J Pharmacol. 1990 Nov 13;190(3):403-7. doi: 10.1016/0014-2999(90)94206-d. Eur J Pharmacol. 1990. PMID: 2125564
Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brain.
Lappalainen J, Hietala J, Sjöholm B, Syvälahti E. Lappalainen J, et al. Eur J Pharmacol. 1990 Apr 25;179(3):315-21. doi: 10.1016/0014-2999(90)90171-2. Eur J Pharmacol. 1990. PMID: 1973105
167 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback